Document:

EMPLOYMENT
AGREEMENT

 

This
Employment Agreement (the “Agreement”) dated as of the 9th day of December, 2021 (the “Effective Date”)
is between Applied UV, Inc., a Delaware corporation (the “Company”), and James Alecxih, an individual residing at
3780 N. Berkeley Lake Road, Duluth, GA 30096 (“Executive”).

 

W
I T N E S S E T H:

 

A. The
Company desires to hire Executive as a Chief Executive Officer and Executive desires to accept such employment.

 

B. The
Company and Executive desire to set forth in this Agreement the terms, conditions and obligations of the parties with respect to such
employment, and this Agreement is intended by the parties to supersede all previous understandings, whether written or oral, concerning
such employment.

 

NOW,
THEREFORE, for and in consideration of the premises and the mutual covenants contained herein, the parties agree as follows:

 

1. 
Employment. The Company hereby employs Executive as the Chief Executive Officer of the Company and President of SteriLumen, Inc.,
a wholly-owned subsidiary of the Company and Executive hereby accepts such employment, subject to the terms and conditions hereof. During
the Term of Employment, the Executive shall be responsible for the performance of those duties consistent with the Executive’s
position as Chief Executive Officer of the Company. The Executive shall serve upon, and report to, the Company’s Board of Directors
(the “Board”) and shall perform and discharge faithfully, diligently, and to the best of the Executive’s ability, the
Executive’s duties and responsibilities hereunder and under the Bylaws of the Company. The Executive’s continued service
on the Board shall be subject to, along with the other members of the Board, the election of shareholders at the company’s annual
meetings. Any termination of the Executive pursuant to Section 7, shall constitute an automatic resignation from the Board. Additionally,
Executive shall perform services and hold positions at other Affiliates (as defined in Section 5) as directed by the Board. It is acknowledged
that Executive may, from time to time, serve on Boards of business entities that are not affiliated with the Company, which entities
do not compete with the Company and where the role of participation is in a non-executive role. Except for such Board service (and the
personal endeavors described below), Executive shall not, without the written approval of the Company, render services of a business
or commercial nature on his own behalf or on behalf of any person, firm, or corporation, for compensation that will interfere with his
performance of duties hereunder. . 

2. 
Location. As may be necessary to perform Executive’s duties hereunder from time to time, the Executive shall work out of
such office as the Company may establish in the Greater Atlanta Metropolitan Area. Executive shall travel as reasonably required by the
Executive’s job duties.

3. 
Term. The Term of this Agreement is two (2) years commencing on the Effective Date and ending on the second anniversary of the
Effective Date and shall be automatically extended for an additional consecutive two (2) year period on the second (2nd) anniversary
of the Effective Date and each subsequent two (2) year anniversary thereof, unless and until the Company or Executive provides written
notice to the other party not less than one hundred and eighty (180) days before such anniversary date that such party is electing not
to extend the Term, in which case the Term shall end at the expiration of the Term as last extended, unless sooner terminated as set
forth in Section 7.

4. 
Compensation; Benefits.

(a) 
Salary. During the Term of this Agreement, the Company agrees to pay Executive an annual salary of $400,000 (the “Salary”).
The Salary shall be payable in accordance with the Company’s regular payroll schedule and will be subject to payroll taxes and
other customary payroll deductions.

(b) 
Annual Discretionary Bonus: Following the end of each calendar year beginning with the 2022 calendar year, the Executive will
be eligible to receive an annual performance bonus targeted of up to 125% of the Executive’s Base Salary (the “Target Bonus”),
based upon periodic assessments of the Executive’s performance as well as the achievement of specific individual and corporate
objectives determined by the Board or a committee thereof after consultation with the Executive and provided to the Executive in writing
no later than the end of the first calendar quarter of the applicable bonus year. The Target Bonus must be approved by the Audit and
Compensation Committee. Except as specified in Paragraph 8(b) below, no amount of annual bonus is guaranteed, and with the exception
of the circumstances described in Paragraph 8(b) below, the Executive must be an employee on December 31 of the applicable bonus year
in order to be eligible for any annual bonus for such year. Any bonus will be paid no later than March 15 of the calendar year following
the calendar year to which the bonus relates. 

 

(c) 
Equity Awards. Effective as of the Effective Date, the Board or a committee thereof shall grant the Executive (i) 75,000 shares
of restricted common stock of the Company and (ii) a ten (10) year option to purchase 175,000 shares of common stock of the Company,
at a per share price equal to the fair market value on the Effective Date (collectively, the “Equity Awards”). The Equity
Awards shall be subject to a quarterly vesting schedule and vest evenly over a three (3) year period, commencing on the Effective Date.
No portion of the Equity Awards shall be vested on the Effective Date. Any options granted by the Company to the Executive that have
vested shall terminate and not be exercisable ninety (90) days after of the termination of the Executive. 

(d) 
Other Benefits. During the Term of Executive’s employment, Executive shall be entitled to participate the Company-funded
healthcare insurance plan and in all other benefits, perquisites, vacation days, benefit plans or programs of the Company which are available
generally to office employees and other employees of the Company in accordance with the terms of such plans, benefits or programs. Company
will pay Executive’s portions of benefit plan. During the Term, the employee will be entitled to four (4) weeks’ vacation
time during each year. 

(e) 
Expenses. Executive shall be reimbursed for Executive’s reasonable and approved expenses related to and for promoting the
business of the Company, including expenses for travel and similar items that arise out of Executive’s performance of services
under this Agreement.

5. 
Extent of Service. The Executive agrees to devote his business time, loyalty, attention, skill and efforts to the faithful performance
and discharge of his duties and responsibilities as Chief Executive Officer of the Company in conformity with professional standards
and in a manner consistent with the obligations imposed under applicable law. The Executive shall promote the interests of the Company
and each other company or other organization which is controlled directly or indirectly by the Company (each an “Affiliate”
and collectively the “Affiliates”) in carrying out the Executive’s duties and responsibilities. The Executive
may serve on the board of directors of other companies, which service shall not interfere with the performance of Executive’s duties
hereunder. 

6. 
Covenants Regarding Confidential Information and Other Matters. All payments and benefits to Executive under the Agreement shall
be subject to Executive’s compliance with the provisions of this Section 6. For purposes of this Section 6, the term “Company”
shall mean, Applied UV, Inc. and any direct or indirect wholly or majority owned subsidiary of the Company.

(a) 
Confidential Information; Inventions. (i) The Executive shall not disclose or use at any time, either during the Term of this
Agreement or thereafter, any Confidential Information (as defined below) of which the Executive is or becomes aware, whether or not such
information is developed by him, except to the extent that such disclosure or use is directly related to and required by the Executive’s
performance in good faith of duties for the Company. The Executive will take all appropriate steps to safeguard Confidential Information
in his possession and to protect it against disclosure, misuse, espionage, loss and theft. The Executive shall deliver to the Company
at the end of the Term, or at any time the Company may request, all memoranda, notes, plans, records, reports, computer tapes and software
and other documents and data (and copies thereof) relating to the Confidential Information or the Work Product (as hereinafter defined)
of the business of the Company which the Executive may then possess or have under his control. Notwithstanding the foregoing, the Executive
may truthfully respond to a lawful and valid subpoena or other legal process, but shall give the Company the earliest possible notice
thereof, shall, as much in advance of the return date as possible, make available to the Company and its counsel the documents and other
information sought, and shall assist the Company and such counsel in resisting or otherwise responding to such process. 

(ii) 
As used in this Agreement, the term “Confidential Information” means information that is not generally known to the
public and that is used, developed or obtained by the Company in connection with its business, including, but not limited to, information,
observations and data obtained by the Executive while employed by the Company or any predecessors thereof (including those obtained prior
to the Effective Date) concerning (i) the business or affairs of the Company (or such predecessors), (ii) products or services,
(iii) fees, costs and pricing structures, (iv) designs, (v) analyses, (vi) drawings, photographs and reports, (vii) computer
software, including operating systems, applications and program listings, (viii) flow charts, manuals and documentation, (ix) data
bases, (x) accounting and business methods, (xi) inventions, devices, new developments, methods and processes, whether patentable
or unpatentable and whether or not reduced to practice, (xii) customers and clients and customer or client lists, (xiii) other
copyrightable works, (xiv) all production methods, processes, technology and trade secrets, and (xv) all similar and related
information in whatever form. Confidential Information will not include any information that has been published (other than through a
disclosure by the Executive in breach of this Agreement) in a form generally available to the public prior to the date the Executive
proposes to disclose or use such information. Confidential Information will not be deemed to have been published merely because individual
portions of the information have been separately published, but only if all material features comprising such information have been published
in combination. 

(iii) 
As used in this Agreement, the term “Work Product” means all inventions, innovations, improvements, technical information,
systems, software developments, methods, designs, analyses, drawings, reports, service marks, trademarks, trade names, logos and all
similar or related information (whether patentable or unpatentable, copyrightable, registerable as a trademark, reduced to writing, or
otherwise) which relates to the Company’s actual or anticipated business, research and development or existing or future products
or services and which are conceived, developed or made by the Executive (whether or not during usual business hours, whether or not by
the use of the facilities of the Company, and whether or not alone or in conjunction with any other person) while employed by the Company
(including those conceived, developed or made prior to the Effective Date) together with all patent applications, letters patent, trademark,
trade name and service mark applications or registrations, copyrights and reissues thereof that may be granted for or upon any of the
foregoing. All Work Product that the Executive may have discovered, invented or originated during his employment by the Company prior
to the Effective Date, or that he may discover, invent or originate during the Period of Employment, shall be the exclusive property
of the Company, as applicable, and Executive hereby assigns all of Executive’s right, title and interest in and to such Work Product
to the Company, including all intellectual property rights therein. Executive shall promptly disclose all Work Product to the Company,
shall execute at the request of the Company any assignments or other documents the Company may deem necessary to protect or perfect its
rights therein, and shall assist the Company, at the Company’s expense, in obtaining, defending and enforcing the Company’s
rights therein. The Executive hereby appoints the Company as his attorney-in-fact to execute on his behalf any assignments or other documents
deemed necessary by the Company to protect or perfect the Company, the Company’s rights to any Work Product. As used herein Work
Product does not include purely personnel endeavors (such as writing a book on unrelated business ventures and/or the development of
business concepts unrelated to the business of the Company) and the Company makes no claim of any rights to such activities. 

(b) 
Restriction on Competition. Executive agrees that if the Executive were to become employed by, or substantially involved in, the
business of a competitor that manufactures or distributes products that compete directly with the products of the Company (“Restricted
Competitor) during the Restricted Period (defined below), it would be very difficult for the Executive not to rely on or use the Company’s
trade secrets and confidential information. Thus, to avoid the inevitable disclosure of the Company’s trade secrets and confidential
information, and to protect such trade secrets and confidential information and the Company’s relationships and goodwill with customers,
during the Restricted Period, the Executive will not directly or indirectly through any other Person engage in, enter the employ of,
render any services to, have any ownership interest in, nor participate in the financing, operation, management or control of, any Restricted
Competitor of the Company in the United States or globally. 

(c) 
Non-Solicitation of Clients by Executive. Executive agrees that for so long as Executive is employed by the Company and continuing
for one (1) year thereafter (such period is referred to as the “Restricted Period”) Executive shall not solicit or
attempt to solicit the business of any customers or clients of the Company with respect to services that the Company performs for such
customers or clients regardless of how or when the Executive first obtained business from or provided services to such customers or clients.

(d) 
Non-Solicitation of Employees. Executive agrees that during the Restricted Period not to directly or indirectly, by sole action
or in concert with others, induce or influence, or seek to induce or influence any person who is currently engaged by the Company at
the time of the termination of Executive’s employment as an employee, agent, independent contractor, or otherwise to leave the
employ of the Company or any successor or assign, or to hire any such person. 

(e) 
Non-Disparagement. During Executive’s employment with the Company and at any time thereafter, Executive shall not, directly
or indirectly, engage in any conduct or make any statement, whether in commercial or noncommercial speech, disparaging or criticizing
in any way the Company, or any of their respective officers, directors, employees, customers or agents or any products or services offered
by any of them, nor shall Executive engage in any other conduct or make any other statement that could be reasonably expected to impair
the goodwill of any of them. 

(f) 
Understanding of Covenants. The Executive acknowledges that, in the course of his employment with the Company, he has become familiar,
or will become familiar, with the Company’s trade secrets and with other confidential and proprietary information concerning the
Company and that his services have been and will be of special, unique and extraordinary value to the Company. The Executive agrees that
the foregoing covenants set forth in this Section 6 (together, the “Restrictive Covenants”) are reasonable and
necessary to protect the Company’s trade secrets and other confidential and proprietary information, good will, stable workforce,
and customer relations.

Without
limiting the generality of the Executive’s agreement in the preceding paragraph, the Executive (i) represents that he is familiar
with and has carefully considered the Restrictive Covenants, (ii) represents that he is fully aware of his obligations hereunder,
(iii) agrees to the reasonableness of the length of time, scope and geographic coverage, as applicable, of the Restrictive Covenants,
(iv) agrees that the Company currently conducts business throughout the continental United States and the rest of the world, and
(v) agrees that the Restrictive Covenants will continue in effect for the applicable periods set forth above in this Section 6
regardless of whether the Executive is then entitled to receive severance pay or benefits from the Company. The Executive understands
that the Restrictive Covenants may limit his ability to earn a livelihood in a business similar to the business of the Company, but he
nevertheless believes that he has received and will receive sufficient consideration and other benefits as an employee of the Company
and as otherwise provided hereunder or as described in the recitals hereto to clearly justify such restrictions which, in any event (given
his education, skills and ability), the Executive does not believe would prevent him from otherwise earning a living. The Executive agrees
that the Restrictive Covenants do not confer a benefit upon the Company disproportionate to the detriment of the Executive.

(g) 
Remedies for Breach of Covenants. (i) In the event that a Restrictive Covenant shall be deemed by any court to be unreasonably
broad in any respect, it shall be modified in order to make it reasonable and shall be enforced accordingly; provided, however, that
in the event that any court shall refuse to enforce any of the Restrictive Covenants, then the unenforceable covenant shall be deemed
eliminated from the provisions of this Agreement for the purpose of those proceedings to the extent necessary to permit the remaining
covenants to be enforced so that the validity, legality or enforceability of the remaining provisions of this Section 6 shall not be
affected thereby.

(ii)
Executive acknowledges that any breach of the Restrictive Covenants may cause irreparable harm to the Company which will be difficult
if not impossible to ascertain, and the Company shall be entitled to seek equitable relief, including injunctive relief, against any
actual or threatened breach hereof, without bond and without liability should such relief be denied, modified or vacated. Neither the
right to obtain such relief nor the obtaining of such relief shall be exclusive of or preclude the Company from any other remedy the
Company or may have hereunder or at law or equity.

7. 
Termination. This Agreement and the employment of the Executive shall terminate upon the occurrence of the following events.

(a) 
Death or Disability. This Agreement and the employment of the Executive shall terminate upon the death or of the Executive of
the finding by the Company’s Board of Directors that the Executive has a Disability. “Disability” means a physical
or mental impairment, which as reasonably determined by the Board, prevents the Executive from performing the essential functions of
the Executive’s position for a period of more than any three (3) months in any six (6)-month period. 

(b) 
Termination by the Company. This Agreement and the employment of the Executive shall terminate at the election of the Company,
with or without “Cause” (as defined below), immediately upon written notice by the Company to the Executive. “Cause”
means for purposes of this Section 7: Any of the following acts that are committed by the Executive (1) continued willful failure, as
determined in the reasonable good faith discretion of the Board, to perform the Executive’s assigned duties or responsibilities
as directed or assigned by the Board (other than due to death or Disability) after written notice thereof from the Board describing in
reasonable detail the failure to perform and providing the Executive a reasonable opportunity to address such alleged failure; (2) being
convicted of, or entering a plea of nolo contendere to a felony or committing any act of moral turpitude, dishonesty or fraud against
the Company or its Affiliates; (3) intentional damage to the Company’s assets or reputation caused by the Executive; (4) breach
by the Executive of Sections 6 or 10(a)(iv) of this Agreement; (5) intentional engagement by the Executive in any competitive activity
which would constitute a breach of the Executive’s duty of loyalty to the Company; or (6) willful conduct by the Executive that
is demonstrably and materially injurious to company, monetarily or otherwise. Failure to meet performance standards or objectives, by
itself, does not constitute “Cause.” No finding of Cause shall be effective unless and until the Board votes to terminate
the Executive’s employment for Cause at a Board meeting or by unanimous written consent.

(c) 
Termination by the Executive. This Agreement and the employment of the Executive shall terminate at the election of the Executive,
with or without “Good Reason” (as defined below), upon written notice by the Executive to the Company (subject, if it is
with Good Reason, to the timing provisions set forth in the definition of Good Reason); provided that if the termination is without Good
Reason, the Executive will provide ninety (90) days written notice to the Company. 

“Good
Reason” means (without the Executive’s consent) (i) a material diminution of the Executive’s base compensation;
(ii) a material diminution in the Executive’s duties, authority or responsibilities, including without limitation, a material change
in the Executive’s reporting responsibilities such that the Executive no longer reports directly to the Board or any successor
to the Company’s Board, ; (iii) the Company’s requiring the Executive to relocate the Executive’s primary office more
than sixty (60) miles from the Executive’s then current primary office; (iv.) any acquirer, successor or assign of the Company
fails to assume and perform, in all material respects, the obligations of the Company hereunder.

 

provided,
however, that in each case, the Company shall have a period of not less than thirty (30) days to cure any act constituting Good Reason
following the Executive’s delivery to the Company of written notice within ninety (90) days of the action or omission constituting
Good Reason and the Executive shall actually terminate the Executive’s employment within thirty (30) days following the expiration
of the Company’s cure period if the Company has not cured.]

 

8. 
Effect of Termination. 

(a) All
Terminations Other Than by the Company Without Cause or by the Executive With Good Reason . If the Executive’s employment is
terminated under any circumstances other than a termination by the Company without Cause or a termination by the Executive with Good
Reason (including a voluntary termination by the Executive without Good Reason or a termination by the Company for Cause or due to the
Executive’s death or Disability), the Company’s obligations under this Agreement shall immediately cease and the Executive
shall only be entitled to receive (i) the Salary that has accrued and is unpaid and to which the Executive is entitled as of the effective
date of such termination and to the extent consistent with general Company policy, to be paid in accordance with the Company’s
established payroll procedure and applicable law but no later than the next regularly scheduled pay period, (ii) unreimbursed business
expenses for which expenses the Executive has timely submitted appropriate documentation, and (iii) any bonus earned and approved by
the Board but not yet paid; (iv) any amounts or benefits to which the Executive is then entitled under the terms of the benefit plans
then-sponsored by the Company in accordance with their terms (and not accelerated to the extent acceleration does not satisfy Section
409A of the Internal Revenue Code of 1986, as amended, (the “Code”)) (the payments described in this sentence, the “Accrued
Obligations”).

(b)
Termination by the Company Without Cause or by the Executive With Good Reason. If the Executive’s employment is terminated
by the Company without Cause or by the Executive with Good Reason, the Executive shall be entitled to the Accrued Obligations. In addition,
the Company shall: (i) continue to pay to the Executive, in accordance with the Company’s regularly established payroll procedures,
the Executive’s Base Salary for a period of twelve (12) months; (ii) pay to the Executive, in a single lump sum on the Payment
Date (as defined below) an amount in cash equal to the pro-rated amount of any the Target Bonus for the year in which Executive is terminated
and (iii) continue Employee’s health benefit under COBRA for a maximum of 12 months or until such time the Executive qualifies
for health benefits from a new employer, whichever is less (collectively, the “Severance Benefits”).

(c)
Release. As a condition of the Executive’s receipt of the Severance Benefits, the Executive must execute and deliver to
the Company a severance and release of claims agreement in a reasonable form to be provided by the Company (which shall include a release
of all releasable claims, reaffirmation of continuing obligations, and confidentiality and reasonable cooperation obligations, but shall
not expand the Executive’s then-existing restrictive covenants or impose restrictive covenant obligations on the Executive that
do not then exist) (the “Severance Agreement”), which Severance Agreement must become irrevocable within sixty (60) days
following the date of the Executive’s termination of employment (or such shorter period as may be directed by the Company). The
Severance Benefits will be paid or commence to be paid in the first regular payroll beginning after the Severance Agreement becomes effective,
provided that if the foregoing sixty (60) day period would end in a calendar year subsequent to the year in which the Executive’s
employment ends, the Severance Benefits will not be paid or begin to be paid before the first payroll of the subsequent calendar year
(the date the Severance Benefits commence pursuant to this sentence, the “Payment Date”). The Executive must not materially
breach the Confidentiality Agreement or the Severance Agreement in order to be eligible to receive or continue receiving the Severance
Benefits.

9. 
Withholding of Taxes. The Company may withhold from any benefits payable under the Agreement all federal, state, city or other
taxes as shall be required pursuant to any law or governmental regulation or ruling.

10. 
Executive’s Representations and Understandings. 

(a) 
Executive represents and warrants to the Company that (i) Executive is free to enter into this Agreement, (ii) this Agreement and Executive’s
obligations hereunder do not violate the terms of any other agreement to which Executive is a party or by which Executive is bound,(iii)
Executive is not subject to any confidentiality agreement, non-competition agreement, non-solicitation agreement or any other similar
agreement that restricts Executive’s ability to perform the services for the Company for which Executive was hired and (iv) other
than as has been expressly disclosed to the Company by the Executive, the Executive has not been (1) arrested or indicted for a felony
crime, a misdemeanor crime involving fraud, dishonesty or illegal drug possession; (2) the subject of a formal complaint filed by a co-worker
with a former employer involving sexual harassment or other abusive behavior or (3) during the last ten (10) years been involved as the
subject of any of the events described in Item 401 (f) of Regulation S-K under the Securities Act of 1933, as amended. The Executive
understands and acknowledges that the Company is a publicly traded company subject to the rules and regulations of the Securities and
Exchange Commission and The NASDAQ Stock Market LLC and as such its Chief Executive Officer’s background is important to the Company’s
continued good standing with these regulators, the representations contained in clause (iv) of this Section 10(a) are consistent with
the Company’s efforts to maintain such good standing and any breach of clause (iv) would cause the Company material harm.

 

(b) 
Executive understands and agrees to comply with all of the written rules and procedures governing employment with the Company, and any
direct or indirect wholly or majority owned subsidiary of the Company, including but not limited to the Company’s Executive Handbook,
written supervisory procedures, and any other employment, compliance, and/or supervisory documents the Company issues from time to time.

 

11. 
Severability. If any provision of this Agreement, as applied to any party or to any circumstance, shall be found by a court to
be void, invalid or unenforceable, the same shall in no way affect any other provision of this Agreement or the application of any such
provision in any other circumstance, or the validity or enforceability of this Agreement.

12. 
Entire Understanding. This Agreement contains the entire understanding of the parties hereto relating to the subject matter contained
herein and supersedes all prior and collateral agreements, understandings, statements and negotiations of the parties. Each party acknowledges
that no representations, inducements, promises or agreements, oral or written, with reference to the subject matter hereof have been
made other than as expressly set forth herein. This Agreement may not be modified or rescinded except by a written agreement signed by
both parties.

13. 
Notices. All notices under this Agreement shall be in writing and shall be (a) delivered in person, (b) sent by e-mail, or (c)
mailed, postage prepaid, either by registered or certified mail, return receipt requested, or overnight express carrier, addressed in
each case as set forth on the signature page hereto (or such other address as may be designated by the party by giving notice in accordance
with this Section. All notices sent pursuant to the terms of this Section shall be deemed received (i) if personally delivered, then
on the date of delivery; (ii) if sent by e-mail before 2:00 p.m. local time of the recipient, on the day sent if a business day or if
such day is not a business day or if sent after 2:00 p.m. local time of the recipient, then on the next business day; (iii) if sent by
overnight, express carrier, on the next business day immediately following the day sent; or (iv) if sent by registered or certified mail,
on the earlier of the third business day following the day sent or when actually received. 

14. 
Consideration. Executive acknowledges that Executive’s continued employment during the term of this Agreement and the other
compensation and benefits provided in this Agreement are sufficient compensation and consideration for purposes of entering into the
restrictions and limitations provided herein, including, but not limited to, the restrictions and limitations set forth in Section 6.

15. 
Waiver. Failure by either party to insist upon strict compliance with any of the terms, covenants or conditions hereof shall not
be deemed a waiver of such term, covenant or condition, nor shall any waiver or relinquishment of any right or remedy hereunder at any
time be deemed a waiver or relinquishment of such right or remedy.

16. 
Governing Law. This Agreement and the rights and obligations of the parties hereunder shall be governed by and construed in accordance
with the laws of the State of Georgia applicable to contracts made and to be performed therein.

17. 
No Presumption. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation
against the party drafting or causing any instrument to be drafted.

18. 
Counterparts. This Agreement may be executed in multiple counterparts, all of which together shall constitute one and the same
instrument.

 

IN
WITNESS WHEREOF, the parties have executed this Employment Agreement as of the day and year first above written.

 

	 	EXECUTIVE
	 	 
	 	 

    ______________________________

    James
Alecxih 

	 	 
	 	 
	 	 
	APPLIED
                                            UV, INC.

    

     

     

    By:

    Name:Max
    Munn

    Title:
    PresidentEX-10.1

 Exhibit 10.1 

FIRST AMENDMENT 

PERFORMANCE-BASED RESTRICTED SHARE UNIT AGREEMENT 

This First Amendment (this “Amendment”) to the Performance-Based Restricted Share Unit Agreement granted as of
February 26, 2019 to John J. Haley (the “PRSU Agreement”), is by and between Willis Towers Watson Public Limited Company (the “Company”) and Mr. Haley, dated as of December __, 2021. Capitalized terms
not defined herein have the meanings set forth in the PRSU Agreement. 
 WHEREAS, Mr. Haley is retiring from the Company on
December 31, 2021, and the Company wishes to amend the PRSU Agreement to provide for the settlement of the PRSUs on the retirement date at the request of Mr. Haley, in the manner set forth in this Amendment; and 

WHEREAS, the PRSU Agreement may be amended by written agreement of the parties. 

NOW, THEREFORE, in consideration of the promises and mutual agreements contained in the PRSU Agreement and this Amendment, the sufficiency of
which is hereby acknowledged, the parties hereto hereby agree to amend the PRSU Agreement as follows: 

1.    Amendment to PRSU Agreement 

(a)    Definition of Vesting Date. Section 1.16 of the PRSU Agreement is hereby deleted in its entirety and
replaced with the following: 
 “Vesting Date” shall mean December 31, 2021, the date of the Colleague’s Qualifying Retirement from the
Company.” 
 (b)    Settlement of Earned Performance Shares. Section 3.2 of the PRSU Agreement is
hereby amended by deleting paragraph (k) thereof and replacing it in its entirety with the following: 
 “(k)
    Earned Performance Shares that become vested on the Vesting Date shall be delivered as follows: (i) the Preliminary Earned Performance Shares shall be delivered on or prior to the Vesting Date, and (ii) the Final
Earned Performance Shares shall be delivered on or within ten (10) days after the Vesting Date. For purposes of the foregoing, (ii) the “Preliminary Earned Performance Shares” shall be ninety-five percent (95%) of the
number of Shares determined under Schedule C based on a deemed partial Performance Period ending on December 29, 2021 (with the “Ending Share Price” calculated with reference to the 28 trading days ending on December 28, 2021);
and (y) the “Final Earned Performance Shares” shall be the number of Shares determined under Schedule C based on the full Performance Period ending on December 31, 2021, reduced by the number of Preliminary Earned
Performance Shares. The Preliminary Earned Performance Shares and the Final Earned Performance Shares shall be determined by the Committee in its sole discretion in accordance with the Performance Objectives set forth in Schedule C and as otherwise
described above. Notwithstanding the foregoing, in the event that the number of Shares delivered to the Colleague at any time as provided above is determined to be greater than the number of Final Performance Shares as determined by the Committee,
the Colleague shall be required to return to the Company, within 30 days of notice by the Company, such excess number of Shares previously delivered to the Colleague.” 

 2.    Effectiveness. All of the provisions of this Amendment
shall be effective as of the date first set forth above. Except as specifically provided for in this Amendment, all of the terms of the PRSU Agreement shall remain unchanged and are hereby confirmed and remain in full force and effect. 

3.    Effect of Amendment. Whenever the PRSU Agreement is referred to in the PRSU Agreement or in any other
agreements, documents or instruments, such reference shall be deemed to be to the PRSU Agreement as amended by this Amendment. 

4.    Counterparts. This Amendment may be executed in two (2) or more counterparts (including by electronic
transmission), each of which shall constitute an original, and all of which taken together shall constitute one and the same instrument. 

5.    Governing Law; Incorporation by Reference. This Amendment, all questions concerning the construction,
interpretation and validity of this Amendment, the rights and obligations of the parties hereto, all claims or causes of action (whether in contract, tort or statute) that may be based upon, arise out of or relate to this Amendment, and the
negotiation, execution or performance of this Amendment (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Amendment or as an inducement to enter this
Amendment) shall be governed by and construed in accordance with the laws of Ireland without regard to its conflicts of law provisions. 

IN WITNESS WHEREOF, the undersigned have executed this Amendment as of the date first set forth above. 

 

			
	COMPANY:
	
	Willis Towers Watson Public Limited Company
		
	By:	 	
                     

		 	Name:
		 	Title:
	
	JOHN J. HALEY:
	
	
                     

  
 2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]